THE ROLE OF METABOLIC AND IMMUNOLOGICAL DISORDERS IN THE DEVELOPMENT OF CHRONIC HEPATITIS C
DOI:
https://doi.org/10.34921/amj.2022.3.006Keywords:
xronik hepatit C, qaraciyər steatozu, qaraciyər fibrozu, qaraciyərin qeyri-alkohol mənşəli piy distrofiyasıAbstract
The article provides information about the study of the impact of metabolic and immunological disorders on chronic viral hepatitis C (CHC). 126 patients with CHC were under observation. Progressive fatty degeneration of the liver – grade III steatosis – was detected mainly in patients with F3 and F4 stages of fibrosis, in 33.3% and 42.9% of cases, respectively. The results showed that metabolic disorders significantly aggravated the course of CHC, and a correlation was observed between the degree of steatosis and the stages of fibrosis. The direct correlation was found between the frequency of diabetes mellitus in CHC patients and the stages of fibrosis; Diabetes mellitus was diagnosed in 73.3% of patients with stages F3-4. Changes in the levels of CD118+ and CD119+ - an increasing number and activity, can be proposed as the immunological criterion for predicting severe liver fibrosis.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Azerbaijan Medical Journal

This work is licensed under a Creative Commons Attribution 4.0 International License.


